Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults
- Status
- COMPLETED
- Phase
- PHASE4
Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b
- Status
- COMPLETED
- Phase
- PHASE1
The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MK-3475/BCG in High Risk Superficial Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy
- Status
- COMPLETED
- Phase
- PHASE4
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
- Status
- COMPLETED
- Phase
- PHASE4
Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients
- Status
- COMPLETED
- Phase
- N/A
Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)
- Status
- COMPLETED
- Phase
- PHASE1
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2